Supriya Lifescience Ltd

BSE Code : 543434
NSE Symbol : SUPRIYA
ISIN : INE07RO01027
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

711.30 -9.00(-1.25%)

Open Price (₹)

720.30

Prev. Close (₹)

720.30

Volume (No’s)

99,144

Market Cap (₹)

5,724.74

Low Price (₹)

710.00

High Price (₹)

725.00 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
20-May-2025	27-May-2025	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday May 27 2025 inter alia to: 1. Consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2025. 2. Recommend dividend if any on the Equity Shares of the Company for the financial year ended March 31 2025. This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2025 till 48 hours after declaration of Audited Financial Results on May 27 2025. Kindly take the above information on your records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Tuesday, May 27, 2025, inter-alia considered and approved the following: 1. Audited Financial Results 2. Dividend 3. Appointment of Secretarial Auditors The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 04.10 p.m. Kindly take the above information on your records. (As Per BSE Announcement Dated :27.05.2025)
05-Mar-2025	10-Mar-2025	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2025 inter alia to consider and approve With reference to above subject matter and pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday March 10 2025 at 11.30 a.m at the registered office of the Company to consider and transact the following businesses: 1. Appointment of Company Secretary and Compliance Officer of the Company; 2. Any other matter with the permission of the chair. Kindly take the above information on your records. With reference to above subject matter and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at their meeting held on Monday, March 10, inter alia considered and approved the following businesses: 1. Appointment of Ms. Prachi Sathe bearing Membership No. A-70252 as Company Secretary and Compliance Officer of the Company with effect from March 10, 2025, on the basis of recommendations received from the Nomination and Remuneration Committee of the Company; 2. Any other matters incidental with the appointment of Company Secretary and Compliance Officer of the Company; Brief profile as per SEBI circular is attached. The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.00 noon. Kindly take the same on record. (As Per Bse Announcement Dated on 10.03.2025)
16-Jan-2025	24-Jan-2025	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2024. Please find the attachment. Please be informed that the Board of Directors of the Company at its Meeting held on Friday, January 24, 2025, has approved the Unaudited Financial Results and appointed Directors as per attachment. (As Per BSE Announcement Dated on 24/01/2025)
21-Oct-2024	28-Oct-2024	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024 Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Monday, October 28, 2024, inter-alia considered and approved the Unaudited Financial Results for the quarter and half year ended September 30, 2024. Read less.. Please find attachemnt. (As Per BSE Announcement Dated on 28.10.2024)
03-Aug-2024	10-Aug-2024	Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2024. Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Saturday, August 10, 2024, inter-alia, has 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2024 2. Approved the additional Capital Expenditure at Ambernath site for CDMO facility. Read less.. Please find the attachment. (As Per BSE Announcement Dated on 10.08.2024)